The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

By August or September of this year, Petersen said he expects “basically half” of the company’s $8 billion in manufacturing ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

As users continue to leave X (formerly Twitter) en masse, many in favor of the newer Bluesky platform, the European Medicines ...